Change of Chief Financial Officer (Form 6-K)

Change of Chief Financial Officer

On April 24, 2025, Ms. Rui (Kerrie) Zhang notified Akso Health Group (the "Company") of her resignation as Chief Financial Officer ("CFO") of the Company, effective as of April 24, 2025. Ms. Rui (Kerrie) Zhang has advised the Company that her resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company.

To fill the vacancy created by Ms. Rui (Kerrie) Zhang's departure, the Board of Directors of the Company appointed Mr. Zhongliang Xie as CFO, effective April 24, 2025. The appointment of Mr. Xie as CFO has a term of one year and may be extended for successive one-year terms, subject to earlier resignation or removal. The biographical information of Mr. Xie is set forth below.

Mr. Zhongliang Xie has served as the General Manager of Zhongxingcai Guanghua Certified Public Accountants Shaanxi Branch since 2019. He previously served as the General Manager of Beijing Xinghua Certified Public Accountants Xi'an Branch from 2008 to 2018, and as the Finance Manager of Zhongyi Far East Import & Export Co., Ltd. from 2005 to 2008. Mr. Xie has also been the signing CPA and lead audit partner for several bond issuance and annual report projects in China. In addition, he has served as the lead audit partner for the listing and annual reports of numerous companies listed on the National Equities Exchange and Quotations (NEEQ) of China. Mr. Xie is a Chinese Certified Public Accountant (CPA), Certified Asset Appraiser, Chinese Certified Cost Engineer, and a fellow of the International Association of Accountants (FAIA).

There are no family relationships between Mr. Zhongliang Xie and any director of the Company. To the best knowledge of the Company, there is no understanding or arrangement between Mr. Xie and any other person pursuant to which he was appointed as the CFO of the Company.